2-166284767-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001365536.1(SCN9A):c.1660C>A(p.Leu554Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000855 in 1,613,494 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001365536.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN9A | NM_001365536.1 | c.1660C>A | p.Leu554Ile | missense_variant | Exon 12 of 27 | ENST00000642356.2 | NP_001352465.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN9A | ENST00000642356.2 | c.1660C>A | p.Leu554Ile | missense_variant | Exon 12 of 27 | NM_001365536.1 | ENSP00000495601.1 | |||
SCN9A | ENST00000303354.11 | c.1660C>A | p.Leu554Ile | missense_variant | Exon 12 of 27 | 5 | ENSP00000304748.7 | |||
SCN9A | ENST00000409672.5 | c.1660C>A | p.Leu554Ile | missense_variant | Exon 12 of 27 | 5 | ENSP00000386306.1 | |||
SCN9A | ENST00000645907.1 | c.1660C>A | p.Leu554Ile | missense_variant | Exon 12 of 27 | ENSP00000495983.1 | ||||
SCN9A | ENST00000454569.6 | c.1660C>A | p.Leu554Ile | missense_variant | Exon 12 of 15 | 1 | ENSP00000413212.2 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152120Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000362 AC: 9AN: 248514Hom.: 0 AF XY: 0.0000371 AC XY: 5AN XY: 134840
GnomAD4 exome AF: 0.0000910 AC: 133AN: 1461374Hom.: 0 Cov.: 32 AF XY: 0.0000880 AC XY: 64AN XY: 726994
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152120Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74300
ClinVar
Submissions by phenotype
not provided Uncertain:2
The L554I variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The L554I variant was not observed with any significant frequency in approximately 6,000 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project. The L554I variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position where amino acids with similar properties to Leucine are tolerated across species. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. -
The SCN9A c.1660C>A; p.Leu554Ile variant (rs201994523), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 234893). This variant is found in the general population with an allele frequency of 0.0036% (10/279,904 alleles) in the Genome Aggregation Database. The leucine at codon 554 is highly conserved, but computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.326). Due to limited information, the clinical significance of the p.Leu554Ile variant is uncertain at this time. -
Inborn genetic diseases Uncertain:1
The alteration results in an amino acid change:_x000D_ _x000D_ The c.1660C>A (p.L554I) alteration is located in exon 12 (coding exon 11) of the SCN9A gene. This alteration results from a C to A substitution at nucleotide position 1660, causing the leucine (L) at amino acid position 554 to be replaced by an isoleucine (I). The alteration is rare in population databases:_x000D_ _x000D_ Based on data from the Genome Aggregation Databases (gnomAD), the SCN9A c.1660C>A alteration was observed in 0.004% (10/279,904) total alleles studied, with a frequency of 0.012% (3/24,190) in the African subpopulation. The altered amino acid is conserved throughout evolution:_x000D_ _x000D_ The p.L554 amino acid is mostly conserved in available vertebrate species; however, isoleucine is in the reference amino acid in several species. The alteration is predicted tolerated by in silico modeling:_x000D_ _x000D_ The p.L554I alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Generalized epilepsy with febrile seizures plus, type 7;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at